“The Association of Dietary Lutein Plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37”, Opthalmology, vol. 122, pp. 1471-1479, 2015.
, “Changes in Lens Opacities on the Age-Related Eye Disease Study Grading Scale Predict Progression to Cataract Surgery and Vision Loss: Age-Related Eye Disease Study Report No. 34”, Ophthalmology, vol. 122, pp. 888-896, 2015.
, “Ciliary Neurotrophic Factor for Macular Telangiectasia Type 2: Results From a Phase 1 Safety Trial”, Am J Ophthalmol, vol. 159, pp. 659-666.e1., 2015.
, “Genetic Testing in Persons with Age-Related Macular Degeneration and the Use of the AREDS Supplements: To Test or Not to Test?”, Ophthalmology, vol. 122, pp. 212-215, 2015.
, “Intravitreal Sirolimus for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 56, pp. 330-338, 2015.
, “Effect of Long-Chain ω-3 Fatty Acids and Lutein + Zeaxanthin Supplements on Cardiovascular Outcomes: Results of the Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial”, JAMA Intern Med, vol. 174, pp. 763-771, 2014.
, “Experimental Design Issues for Assessment of Carotenoids Lutein and Zeaxanthin in Age-Related Eye Disease Study 2 Formulation for Age-Related Macular Degeneration”, JAMA Ophthalmol, vol. 132, pp. 904-905, 2014.
, “Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1”, Contemporary Clinical Trials, vol. 37, pp. 294-300, 2014.
, “Ten-Year Follow-up of Age-Related Macular Degeneration in the Age-Related Eye Disease Study: AREDS Report No. 36”, JAMA Ophthalmol, vol. 132, pp. 272-277, 2014.
, “Visual Acuity After Cataract Surgery in Patients with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 5”, Ophthalmology, vol. 121, pp. 1229-1236, 2014.
, “Evaluation of Optimized Digital Fundus Reflex Photographs for Lens Opacities in the Age-Related Eye Disease Study 2: AREDS2 Report 7”, Invest Ophthalmol Vis Sci, vol. 54, pp. 5989-5994, 2013.
, “Long-Term Effects of Vitamins C and E, β-Carotene, and Zinc on Age-Related Macular Degeneration: AREDS Report No. 35”, Opthalmology, vol. 120, pp. 1604-1611e.4, 2013.
, “Medical Characteristics of Patients with Macular Telangiectasia Type 2 (MacTel Type 2) MacTel Project Report No. 3”, Ophthalmic Epidemiol, vol. 20, pp. 109-113, 2013.
, “Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)”, Invest Ophthalmol Vis Sci, vol. 54, pp. 4548-4554, 2013.
, “Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration”, Opthalmology, vol. 120, pp. 140-150, 2013.
, “Ten-year Incidence Rates of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS). AREDS Report No. 33”, Ophthalmic Epidemiology, vol. 20, pp. 71-81, 2013.
, “Treatment of Geographic Atrophy with Subconjunctival Sirolimus: Results of a Phase I/II Clinical Trial”, Invest Ophthalmol Vis Sci, vol. 54, pp. 2941-2950, 2013.
, “The Age-Related Eye Disease Study 2 (AREDS2): Study Design and Baseline Characteristics (AREDS2 Report No. 1)”, Ophthalmology, vol. 119, pp. 2282-2289, 2012.
, “The Development of AMD in Participants with No or Small Drusen in the Age-Related Eye Disease Study (AREDS)”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2012.
, “Effective Monitoring Strategies in a Long-term Clinical Trial with Varying Levels of Clinic Staff”, in Society for Clinical Trials, Miami, FL, 2012.
, “"En Face" OCT Imaging of the IS/OS Junction Line in Type 2 Idiopathic Macular Telangiectasia”, Invest Ophthalmol Vis Sci, vol. 53, pp. 6145-6152, 2012.
, “The IS/OS Junction Layer in the Natural History of Type 2 Idiopathic Macular Telangiectasia”, Invest Ophthalmol Vis Sci, vol. 53, pp. 7889-7895, 2012.
, “Spatial Correlation Between Hyperpigmentary Changes on Color Fundus Photography and Hyperreflective Foci on SDOCT in Intermediate AMD”, Invest Ophthalmol Vis Sci, vol. 53, pp. 4626-4633, 2012.
, “Tracking of regulatory documents in a large clinical trial, The Age-Related Eye Disease Study 2”, in Society for Clinical Trials, Miami, FL, 2012.
, “Longitudinal Analysis of Retinal Hemangioblastomatosis and Visual Function in Ocular von Hippel Lindau Disease”, in Association for Research in Vision and Ophthalmology - ARVO, Ft. Lauderdale, FL, 2011.
,